Medicus Pharma issues third debenture for $2.5M, completing $5M Yorkville facility

Medicus Pharma Ltd.

On June 17, 2025, issued third debenture to YA II PN, Ltd. for $2.5M principal, net proceeds $2.25M.
Total aggregate principal from three debentures now $5M; net proceeds to Company $4.5M.
Debentures bear 8% annual interest (18% upon default), mature February 2, 2026, guaranteed by subsidiaries.

item 1.01item 2.03item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.